0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Neurology
Viewpoint  | 
The Importance of Lesbian, Gay, Bisexual, and Transgender Health in Neurology: What’s in a Name?
Nicole Rosendale, MD; S. Andrew Josephson, MD
JAMA
Original Investigation  | 
Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma
Stacy Loeb, MD, MSc; Yasin Folkvaljon, MSc; Mats Lambe, MD, PhD; et al.
JAMA Dermatology
Editorial  | 
Finasteride and the Uncertainties of Establishing Harms
Thomas J. Moore, AB
JAMA Dermatology
Original Investigation  | 
Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis
Steven M. Belknap, MD; Imran Aslam, BS; Tina Kiguradze, BS; et al.